<DOC>
	<DOCNO>NCT01277471</DOCNO>
	<brief_summary>Aims priority project The purpose study 1. test effect frequency meal ( six vs. two meal daily daily caloric restriction -500 kcal/day ) insulin sensitivity , insulin secretion , hepatic fat content . 2. characterize mechanism action different frequency meal ( amount visceral fat , hepatic fat content , serum concentration adipokines , gut hormone , oxidation stress marker ) . 3. test ability participant maintain hypocaloric diet regimen educate leave prepare meal alone comparison meal study provide . It randomize , crossover study , 50 individual type 2 diabetes change random order two regimen : six , two meal day . Each test period take three month . Glucose lipid metabolism regulation thoroughly test start , 3-months-period ( meal test , hyperinsulinemic isoglycemic clamp , indirect calorimetry , MRI scan liver , DXA scan , serum concentration determination select adipokines , gut hormone , oxidation stress marker ) . Hypothesis The investigator hypothesize low plasma insulin level ( achieve period fast ) reduce insulin resistance hepatic lipid content . In contrast , frequent meal ( consequent high plasma level insulin ) predispose non-alcoholic fatty liver disease insulin resistance . The investigator hypothesize participant increase caloric intake increase meal frequency ( spite thorough education ) leave prepare meal comparison meal provide .</brief_summary>
	<brief_title>Effect Meal Frequency Insulin Resistance Subjects With Type 2 Diabetes</brief_title>
	<detailed_description>Aims priority project The purpose study 1. test effect frequency meal ( six vs. two meal daily daily caloric restriction -500 kcal/day ) insulin sensitivity , insulin secretion , hepatic fat content . 2. characterize mechanism action different frequency meal ( amount visceral fat , hepatic fat content , serum concentration adipokines , gut hormone , oxidation stress marker ) . 3. test ability participant maintain hypocaloric diet regimen educate leave prepare meal alone comparison meal study provide . It randomize , crossover study , 50 individual type 2 diabetes change random order two regimen : six , two meal day . Each test period take three month . Glucose lipid metabolism regulation thoroughly test start , 3-months-period ( meal test , hyperinsulinemic isoglycemic clamp , indirect calorimetry , MRI scan liver , DXA scan , serum concentration determination select adipokines , gut hormone , oxidation stress marker ) . Hypothesis The investigator hypothesize low plasma insulin level ( achieve period fast ) reduce insulin resistance hepatic lipid content . In contrast , frequent meal ( consequent high plasma level insulin ) predispose non-alcoholic fatty liver disease insulin resistance . The investigator hypothesize participant increase caloric intake increase meal frequency ( spite thorough education ) leave prepare meal comparison meal provide . Key word Insulin resistance , meal frequency , type 2 diabetes mellitus , non-alcoholic fatty liver disease , adipokines , gut hormone , oxidative stress Methodology Study design : investigator use design randomize , crossover study , 50 individual type 2 diabetes change random order frequency meal : six , two meal day . Caloric restriction ( -500 kcal/day ) . Each test period take three month . For one half participant meal study provide . The half thoroughly educate maintain daily caloric intake regimen prepare meal alone . Study group : 50 individual type 2 diabetes treat diet oral hypoglycemic agent , diabetes duration least 1 year , men woman , age 30-65 year , BMI 27-50 kg/m² . The subject explain aim , method risk study sign inform consent ( Appendix 1 ) . Regimens : On six-meals-per-day-regimen , participant ask divide total caloric intake six meal eat every two three hour . On two-meals-per-day-regimen , divide total caloric intake two meal : first meal eaten 6 10 a.m. , second one noon 4 p.m . Physical activity : Participants ask change exercise habit study . Physical activity monitor use pedometer standardized questionnaire : International Physical Activity Questionnaire ( IPAQ ) , Baecke questionnaire . Procedures : At begin ( week 0 ) , end every 3 month ( week 12 , 24 ) , follow procedure measurement perform subject ( three time subject ) : 1 . Common anthropometric investigation ( body weight , BMI , waist hip circumference ) , blood sample take laboratory assessment ( common laboratory test , parameter glucose lipid metabolism , choose adipokines , oxidative stress marker , gut hormone , fatty acid composition serum phospholipid etc.- see analytic method ) . 2 . Meal test glucose tolerance assessment standard breakfast /baguette Crocodille Cheese Gourmet - 180g , energy 452,8 Kcal/1895,7 kJ , composition : carbohydrates 49,2 g ( 44,55 % ) , proteins 18,5 g ( 16,74 % ) , lipids 18,8 g ( 38,7 % ) , saturate 6,8 g , monounsaturated 6,0 g , polyunsaturated 5,0 g/ . Blood sample assessment glycemia , C- peptide , immunoreactive insulin ( IRI ) take 0 , 30 , 60 , 120 180 minute breakfast . 3 . Hyperinsulinemic ( 1 mU/kg/min ) isoglycemic clamp ( HIC ) 3 hour long indirect calorimetry . This method allow exact quantification insulin resistance energy substrate utilisation . 4 . MRI ( magnetic resonance imaging ) scan liver measure hepatic fat content . 5 . DXA ( Dual energy X-ray absorptiometry ) scan measure total body composition fat content . 6 . Insulin secretion glucose control measure one-day-stay hospital end regimen . Blood sample take every three hour whole day . Urine collect whole day measure microalbuminuria C-peptide waste . Analytic method : Plasma concentration select adipokines ( resistin , adiponectin total , HMW- adiponectin , TNFalfa leptin ) cytokine protein ( FABP ) measure enzymatically use standard kit ( ELISA , Linco , USA ) . Plasma level gut hormone measure enzymatically usig standard kit ( Milliplex , Millipore , USA ) . Parameters lipid peroxidation determine accord level TBARS reaction thiobarbituric acid accord level conjugate dienes . The level reduce oxidised glutathione determine use HPLC method fluorescence detection . Ascorbic acid determine spectrophotometric reaction dinitrophenylhydrazine . Concentrations a- g-tocopherol serum determine reverse-phase high performance liquid chromatography ( HPLC ) fluorescence detection accord modify method Catignani Biery . The activity SOD analyze reaction block nitrotethrazolium blue reduction nitrophormasane formation . Catalase activity measurement base ability H2O2 produce ammonium molybdate color complex detect spectrophotometrically . The activity gluthathione peroxidase monitor oxidation velocity gluthathione Ellman reagent . Serum glucose analyse use glucose-oxidase method Beckman Analyzer ( Beckman Instruments Inc. , Fullerton , CA , USA ) , IRI determine radioimmunoassay use IMMUNOTECH Insulin IRMA kit ( IMMUNOTECH , Prague , Czech Republic ) , C-peptide use IMMUNOTECH C-Peptide IRMA kit ( IMMUNOTECH , Prague , Czech Republic ) glycated hemoglobin measure Bio-Rad Haemoglobin A1c Column Test ( Bio-Rad Laboratories GmbH , Munich , Germany ) . Fatty acid pattern serum phospholipid measure lipid extraction accord Folch separation lipid fraction thin-layer chromatography . The methylesters fatty acid separate gas chromatography . Eventual effect different meal frequency regimen evaluate due choose gene polymorphism . Statistic analysis : Will do use ANOVA test , pair unpair t- test statistic method use standard statistic program . Estimate number subject recruit do use power analysis repeat measurement via statistic software PASS 2005 ( Number Cruncher Statistical Systems , Kaysville , UT , USA ) . Factors include model interindividual factor ( control vs. experimental group ) , intraindividual factor ( individual time stadium study ) interaction factor ( divergence degree time profile control experimental group ) . Time frame : December 2010-February 2011 recruitment participant March 2011 start study Group A : 12 week 6 meals/day follow additional 12 week 2 meal/day Group B : 12 week 2 meals/day follow additional 12 week 6 meal/day September 2011 end study All measurement do start , week 12 week 24 .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>1 . Type 2 diabetes 1 year 2 . Treatment T2D . Oral hypoglycemic agent stable last 3 month 3 . HbA1c ≥4.2 ≤10.5 % ( IFCC ) 4 . Agek 3070 year 5 . Body Mass Index ( kg/m2 ) 27 50 6 . Willingness follow different dietary regimens 7 . The patient least 3 symptom metabolic syndrome 1 . Alcoholism drug abuse 2 . Pregnancy , lactation 3 . Nonstable medication diabetes , hypertension dyslipidemia last 3 month 4 . Diagnosis type 1 diabetes 5 . Weight loss weight gain last 3 month ( &gt; 5 % total body weight ) 6 . Cardiostimulant</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>meal frequency</keyword>
	<keyword>type two diabetes</keyword>
</DOC>